SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042411
Filing Date
2023-08-14
Accepted
2023-08-14 16:11:25
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20230630.htm   iXBRL 10-Q 2758843
2 EX-31.1 dsgn-ex31_1.htm EX-31.1 22771
3 EX-32.1 dsgn-ex32_1.htm EX-32.1 15122
4 EX-99.1 dsgn-ex99_1.htm EX-99.1 3048
5 GRAPHIC img267412975_0.jpg GRAPHIC 201790
  Complete submission text file 0000950170-23-042411.txt   8871878

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20230630_pre.xml EX-101.PRE 232745
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dsgn-20230630_cal.xml EX-101.CAL 38133
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20230630_lab.xml EX-101.LAB 328490
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dsgn-20230630_def.xml EX-101.DEF 121149
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20230630.xsd EX-101.SCH 41948
58 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20230630_htm.xml XML 1753716
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 231170208
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences